Understanding kidney cancer genes in families
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This research study helps doctors understand inherited kidney cancers and related conditions that run in families. Researchers collect medical information and blood samples to identify genetic causes and improve how these conditions are diagnosed and treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 2 years old
- You or a biological family member have (or are suspected to have) an inherited kidney or urologic cancer, OR your family has multiple members with similar cancers
- You or your family member can provide informed consent (a guardian can consent for children under 18)
- Have a blood sample collected for genetic testing
- Be willing to share medical history and possibly undergo imaging tests (depending on study category)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study helps doctors understand a rare genetic condition called HLRCC that causes specific types of skin tumors and kidney cancer to run in families. By studying your genetics and medical history, researchers hope to improve how doctors detect and treat this condition.
This study collects blood and tissue samples from people with cancer or suspected cancer, or from their blood relatives. Researchers use these samples to better understand cancer and develop new treatments.
This research study examines the genes behind Birt-Hogg-Dubé (BHD) syndrome, a condition that increases kidney cancer risk. Researchers want to understand who inherits this condition and how to better identify and help people at risk.
This study looks at genetic features of kidney cancer by testing tumor samples. The goal is to find biomarkers—specific signs—that may help predict what kind of kidney cancer it is.
This study looks for “biomarkers,” which are measurable signs (often from blood or tissue), to better understand kidney cancer. It may help doctors identify who has kidney cancer and how it behaves.
This study uses a urine sample to classify kidney cancer without surgery. It aims to improve diagnosis by analyzing tiny particles released by tumors.
Hear when a new Renal Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.